HCV Healthcare Providers Hub
Providing information and resources to healthcare providers who want to learn more about hepatitis C
New HCV Providers
This path offers essential onboarding information, including key guidelines, resources, and best practices to help you effectively manage hepatitis C in your patients
Existing HCV Providers
This path provides in-depth information, advanced treatment options, and the latest research to enhance your expertise in managing hepatitis C care
HCV Overview
HCV Landscape
An overview of changes in patients with HCV and treatments, emphasizing the role of nonspecialists in care
Extrahepatic Manifestations in HCV Infection
An overview on extrahepatic manifestations among patients with HCV with an emphasis on people who use drugs
WHO: Combating HBV and HCV to Reach Elimination by 2030
Plans to increase prevention, testing, and treatment access to reduce new infections and mortality caused by HBV and HCV
Interested in learning more about the symptoms, testing, and prevention of viral hepatitis, and current elimination plans?
People Who Use Drugs
NASTAD: Community Navigation Model and Toolkit
A toolkit consisting of program protocols, data collection tools, and patient education materials
ASAM: American Society of Addiction Medicine
Resources and support for addiction medicine professionals, including education, advocacy, and clinical practice guidelines
CDC: People Who Inject Drugs and Viral Hepatitis
Information on people who use drugs and viral hepatitis, including CDC guidelines on screening, treatment, and resources
Discover more about the impact of hepatitis C among people who use drugs, including testing, prevention, and elimination efforts
Additional Key Populations
AASLD/IDSA: Guidelines on Men Who Have Sex With Men
Guidelines for HCV screening, treatment, and reinfection among men who have sex with men
CDC: Viral Hepatitis Among People Experiencing Homelessness
Homelessness impacts both physical and mental health, making it difficult to access health care
AASLD/IDSA: Guidelines on Incarcerated Populations
HCV testing and treatment in correctional settings
Discover more about the impact of hepatitis C among people who use drugs, including testing, prevention, and elimination efforts
HCV Screening
HCV Screening Guide
An overview of the AASLD/IDSA guidelines for the screening and diagnosis of patients with hepatitis C
Explore more about hepatitis C screening, including key methods, testing protocols, and strategies for early detection
Pretreatment Assessments
AASLD/IDSA: Simplified HCV Treatment Guidelines
Eligibility, recommended therapies, and monitoring steps for effective HCV treatment in adults new to therapy
Pretreatment Laboratory Assessments
AASLD/IDSA recommendations for pretreatment assessments following an HCV diagnosis
Hepatitis B Reactivation Guide
HBV reactivation causes, complications, assessments, and treatment considerations for patients with HCV/HBV coinfection
Pretreatment Assessment Guide
AASLD/IDSA guidance on HCV screening, diagnosis, treatment, and management
Expand your knowledge about HCV pretreatment assessments. Discover essential evaluations, patient considerations, and recommended practices
On-Treatment Monitoring
On-Treatment Monitoring Guide
AASLD/IDSA guidance for monitoring patients with diabetes or on anticoagulants
Telemedicine: The “New Normal” for Managing HCV Care
A webinar with Dr. Tipu Khan on COVID-19's impact on HCV screening, diagnosis, care, and the role of telemedicine
Specialty Pharmacy Brochure
Essential information on specialty pharmacies and how to collaborate with them effectively
Posttreatment Follow-Up
Posttreatment Follow-Up Guide
Guidance on follow-up for patients who have been treated for HCV infection, based on treatment success
HCV Reinfection Rates in People Who Inject Drugs
Information on HCV reinfection rates and risk reduction strategies for people who inject drugs
Explore additional resources on HCV management, covering on-treatment and posttreatment care, reinfection rates, risk reduction strategies for people who inject drugs, and the importance of outreach and care
